These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33733965)

  • 21. Sodium Tetradecyl Sulphate Sclerotherapy for Lateral Malleolar Bursitis of the Ankle.
    Yoon YK; Park JH; Kim J; Han SH; Shin SH; Lee JW; Park KH
    Clin Orthop Surg; 2022 Jun; 14(2):289-296. PubMed ID: 35685968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
    Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
    Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of foam sclerotherapy with sodium tetradecyl sulfate as preferred sclerosant of venous malformations based on experience from a single specialist center.
    Arasakumar DRB; Pang C; Evans N; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J; Lim CS
    J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):379-388. PubMed ID: 36328136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol.
    Goldman MP
    Dermatol Surg; 2002 Jan; 28(1):52-5. PubMed ID: 11991271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.
    Stuart S; Barnacle AM; Smith G; Pitt M; Roebuck DJ
    Radiology; 2015 Mar; 274(3):897-905. PubMed ID: 25271855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
    Ravi M; Kate V; Ananthakrishnan N
    Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?
    Goldman MP
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1454-6; discussion 1456. PubMed ID: 15606731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies in sclerotherapy: I. Comparison of sodium tetradecyl sulphate (STS) with absolute alcohol (AA) as sclerosants in the treatment of esophageal varices.
    Chawla Y; Dilawari JB
    J Clin Gastroenterol; 1990 Aug; 12(4):378-80. PubMed ID: 2398244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
    Boyer H; Fernandes P; Le C; Yueh B
    Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
    Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse neurological events after sodium tetradecyl sulfate foam sclerotherapy - A prospective, observational study of 8056 treatments.
    Davies HO; Watkins M; Oliver R; Berhane S; Bradbury AW
    Phlebology; 2022 Mar; 37(2):97-104. PubMed ID: 34657519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of High-Dose 3% Sodium Tetradecyl Sulfate for Sclerotherapy of Renal Cysts in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Patel NR; Stella SF; Nasser M; Tai E; Hsiao R; Iliuta IA; Jaberi A; Kachura JR; Pei Y; Shlomovitz E
    J Vasc Interv Radiol; 2022 Jun; 33(6):715-718. PubMed ID: 35636836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel.
    Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M
    Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial.
    Bertanha M; Camargo PA; Moura R; Yoshida WB; Pimenta RE; Mariúba JV; Alcantara GP; de Paula DR; Sobreira ML
    Medicine (Baltimore); 2016 Sep; 95(39):e4812. PubMed ID: 27684809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic facial pain following injection of sodium tetradecyl sulphate into an intraparotid haemolymphangioma.
    Crampsey DP; Cochrane L; Roebuck D; Hartley BE
    J Laryngol Otol; 2008 Sep; 122(9):1002-4. PubMed ID: 17625033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of telangiectasia: comparison of sclerosing agents.
    Carlin MC; Ratz JL
    J Dermatol Surg Oncol; 1987 Nov; 13(11):1181-4. PubMed ID: 3312331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy.
    Potter B; Gobeil F; Oiknine A; Laramée P
    Can J Cardiol; 2010 Apr; 26(4):146-8. PubMed ID: 20386776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interim results on abolishing reflux alongside a randomized clinical trial on laser ablation with phlebectomies versus foam sclerotherapy.
    Lattimer CR; Kalodiki E; Azzam M; Makris GC; Somiayajulu S; Geroulakos G
    Int Angiol; 2013 Aug; 32(4):394-403. PubMed ID: 23822942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
    Conrad P; Malouf GM; Stacey MC
    Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More on hypertrichosis after sclerotherapy.
    Kiripolsky MG
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1066-7. PubMed ID: 20590715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.